Johnson, Jessica A.

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., & Bloch, M. H. (2018) · Neuropsychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 142

Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders

Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019) · Depression and Anxiety

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 131

A scoping review of implementation considerations for Harm Reduction Vending Machines

Russell, E., Johnson, J., Kosinski, Z., Kaplan, C., Barnes, N., Allen, S., & Haroz, E. (2022) · Harm Reduction Journal

HIV, Drug Use, Sexual RiskHealth Policy Implementation Science

Cited by 52

A scoping review of implementation considerations for harm reduction vending machines

Russell, E., Johnson, J., Kosinski, Z., Kaplan, C., Barnes, N., Allen, S., & Haroz, E. (2023) · Harm Reduction Journal

HIV, Drug Use, Sexual RiskHealth Policy Implementation Science

Cited by 52

Meta-analysis: Risk of dry mouth with second generation antidepressants

Cappetta, K., Beyer, C., Johnson, J. A., & Bloch, M. H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Treatment of Major DepressionSalivary Gland Disorders and Functions

Cited by 49